Linaclotide | CAS:851199-59-2

We serve Linaclotide CAS:851199-59-2 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Linaclotide

Chemical Name:Linaclotide
CAS.NO:851199-59-2
Synonyms:Linaclotide
Linaelotide Acetate
 
Physical and Chemical Properties:
Density 1.6±0.1 g/cm3
Boiling Point 2045.0±65.0 °C at 760 mmHg
Molecular Formula C59H79N15O21S6
Molecular Weight 1526.736
Flash Point 1190.5±34.3 °C
Vapour Pressure 0.0±0.3 mmHg at 25°C
Index of Refraction 1.712
 
Specification:
Appearance:White to off-white powder
Assay:≥98.0%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Linaclotide  is apeptide agonist of guanylate cyclase 2C. It was approved by the FDA in August 2012 for the treatment in adults of constipation-predominant irritable bowel syndrome (IBS-C) and chronic idiopathic constipation (CIC).



Contact us for information like Linaclotide chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Linaelotide Acetate physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Linaclotide Use and application,Linaelotide Acetate technical grade,usp/ep/jp grade.


Related News: The API is not made by only one reaction from the raw materials but rather it becomes an API via several chemical compounds.2-(3,5-dibromophenyl)-4,6-diphenyl-1,3,5-triazine manufacturer Pharmaceutical intermediates and APIs belong to the fine chemical industry.6-Fluorochromane-2-carboxylic acid supplier “No two studies are the same, and each carries its own unique risks and presents individual challenges, but the aim of CTSuccess is to use the experience we have as a company in supplying materials for thousands of trials to identify the characteristics of a project upfront and highlight potential risk factors that may arise,” said Kristen Devito, Global Director, Catalent Clinical Supply Services.BOC-CYS(4-MEOBZL)-OH vendor That notice came two days after Chinese President Xi Jinping — a well known TCM advocate — called for the “combination of Chinese and Western medicine” in the diagnosis and treatment of the disease at a meeting of the Communist Party’s Politburo Standing Committee, the country’s supreme ruling body.The move could force international drugmakers to further cut prices and enable copycat medicines to replace imported off-patent brands at faster pace.